Autolus Therapeutics plc (AUTL): Analysts See 697% Upside Potential
We recently published an article titled . Autolus Therapeutics plc (NASDAQ:AUTL) was one of the stocks that was covered in that article. Wall Street analysts believe AUTL has a 697% upside potential over the next 12 months.
A laboratory technician carefully studying a microscope with a biopharmaceutical product inside.
Autolus Therapeutics plc (NASDAQ:AUTL) is a clinical-stage biopharmaceutical company specializing in the development of T-cell therapies for the treatment of cancer and autoimmune diseases. Established in 2014, Autolus is advancing innovative approaches in the field of chimeric antigen receptor (CAR) T-cell therapy, aiming to transform patient outcomes with cutting-edge science and technology.
Autolus has strategically positioned itself to meet global demand through its dedicated commercial manufacturing facility, known as "The Nucleus," located in the UK. This facility not only supports clinical and commercial production requirements but also ensures scalability and flexibility, enabling the company to cater to expanding markets. Autolus retains worldwide commercial rights to its products and maintains a focused marketing strategy targeting key regions such as the United States, the United Kingdom, and Europe. This strategic approach highlights the company's commitment to delivering transformative therapies across diverse geographic markets while ensuring the highest standards of quality in production.
Further analysis of the company's business model and financial performance reflect its significant progress in advancing CAR T-cell therapy. In the first quarter of 2025, Autolus posted revenue of $9 million, demonstrating steady growth. For the full year of 2024, the company reported $45.8 million in revenue, driven by its pioneering efforts in cancer treatment development. With $210 million in cash reserves, Autolus is well-positioned to support the commercialization plans for its therapies and sustain future research and development endeavors. This financial stability has contributed to a positive outlook among analysts, who project the company's share price to reach $9.97 within the next twelve months, offering an upside potential of 697.60%. Through its relentless pursuit of innovation and financial health, Autolus Therapeutics plc remains at the forefront of oncology treatment, pushing boundaries and redefining possibilities in CAR T-cell therapy.
Overall, Autolus Therapeutics plc (NASDAQ:AUTL) ranks 3rd on our list of 13 Best Multibagger Stocks to Invest in Now. While we acknowledge the potential of AUTL to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AUTL and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Low Volatility Stocks to Buy Now and Starter Stock Portfolio: 12 Safe Stocks to Buy
Disclosure: None. This article is originally published at Insider Monkey.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Li Auto Just Slashed Its Forecast--But It's Betting Big on One Make-or-Break EV Launch
Li Auto (NASDAQ:LI), often seen as one of Teslas fiercest challengers in Chinas premium EV market, just dialed back its Q2 delivery guidanceby a lot. The company now expects to ship around 108,000 vehicles this quarter, down from its earlier estimate of 123,000128,000. The drop isnt due to slumping demand or production issues. Instead, management said it's the result of a temporary disruption as Li overhauls its internal sales systeman investment aimed at scaling more efficiently in the long run. Investors may not love the headline number, but this kind of short-term dip is sometimes the price of building for a bigger future. That future might arrive sooner than expected. The company is preparing for the launch of the Li i8, a new model that could redefine its product roadmap and kick off a fresh sales cycle. Executives say the internal restructuring should be done before the i8 hits the streetspositioning Li Auto to embrace the new product cycle with sharper execution and stronger organizational muscle. If the transition goes smoothly, Q3 could look very different. And for investors betting on execution during inflection points, this is the moment to watch. Since beginning volume production in late 2019, Li Auto has steadily built a portfolio of high-tech family EVsfrom the flagship Li MEGA MPV to the five- and six-seat L-series SUVs. Its one of the few players in China to successfully commercialize extended-range EVs while also building out full battery-electric platforms in parallel. While the Q2 miss isnt ideal, the long-term thesis might still hold: this is a company making bold bets on platform scale and product diversificationand taking its lumps now to set up a more competitive second half of 2025. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
What Makes Cisco Systems, Inc. (CSCO) One of the Best Dividend Picks This Year
Cisco Systems, Inc. (NASDAQ:CSCO) is one of the Best Stocks to Buy for Dividends. Engineers using the latest Cisco TelePresence technology to collaborate with colleagues around the world. The company's business remains on solid footing. In March, it introduced its Webex AI agent designed for customer service applications, marking progress in its innovation efforts. Cisco Systems, Inc. (NASDAQ:CSCO) is also effectively managing expenses, with operating costs in fiscal Q3 of 2025 remaining flat compared to the previous year. A slight improvement in gross margin led to a healthy rise in operating income. While the company still generates much of its revenue from established areas like routing and switching, these segments provide a steady cash flow that supports its ongoing business transformation. Cisco Systems, Inc. (NASDAQ:CSCO) continues to return significant capital to shareholders, backed by strong free cash flow. The stock offers a 2.4% dividend yield and benefits from a newly approved $15 billion share buyback program. In the most recent quarter, the company generated $4.1 billion in operating cash flow, up 2% from the same period last year, and returned $3.1 billion to shareholders through dividends and repurchases. Cisco Systems, Inc. (NASDAQ:CSCO)'s acquisition strategy also supports its dividend outlook, especially when deals boost cash flow. A notable example is the company's 2024 acquisition of Splunk, which added about $1.4 billion to fiscal 2024 revenue. It currently offers a quarterly dividend of $0.41 per share. While we acknowledge the potential of CSCO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
How PepsiCo Stays Ahead in Snacks and Beverages
PepsiCo, Inc. (NASDAQ:PEP) is one of the Best Wide Moat Dividend Stocks to Invest in. A close up of a glass of a refreshing carbonated beverage illustrating the company's different beverages. After years of weak growth caused by operational missteps and limited investment, PepsiCo, Inc. (NASDAQ:PEP)'s management has successfully turned things around, delivering steady gains in revenue and profits. However, the company still has more room to grow, supported by strong long-term trends in the snack industry, expansion into high-growth beverage segments like energy drinks, and increasing demand in emerging markets such as Latin America, Africa, and Asia-Pacific. Its integrated business model also helps it bring products to market more efficiently. PepsiCo, Inc. (NASDAQ:PEP) stays ahead of health and wellness trends by introducing zero-sugar and functional beverages and exploring unique flavors, including through its recent acquisition of Poppi. The company owns popular brands like Pepsi, Quaker Oats, and Aquafina, which are staples in grocery stores. Its sales generally remain steady even during economic downturns, giving it a solid advantage in navigating recessions. PepsiCo, Inc. (NASDAQ:PEP) also holds a strong dividend policy. The company has been rewarding shareholders with growing dividends for the past 53 consecutive years. Currently, it offers a quarterly dividend of $1.4225 per share and has a dividend yield of 4.34%, as of June 24. While we acknowledge the potential of PEP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Sign in to access your portfolio
